Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity

Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical rol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta pharmacologica Sinica 2013-04, Vol.34 (4), p.522-530
Hauptverfasser: Wan, Chun-ping, Gao, Li-xin, Hou, Li-fei, Yang, Xiao-qian, He, Pei-lan, Yang, Yi-fu, Tang, Wei, Yue, Jian-min, Li, Jia, Zuo, Jian-ping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 530
container_issue 4
container_start_page 522
container_title Acta pharmacologica Sinica
container_volume 34
creator Wan, Chun-ping
Gao, Li-xin
Hou, Li-fei
Yang, Xiao-qian
He, Pei-lan
Yang, Yi-fu
Tang, Wei
Yue, Jian-min
Li, Jia
Zuo, Jian-ping
description Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases.
doi_str_mv 10.1038/aps.2012.208
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4002795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>45518997</cqvip_id><sourcerecordid>1324390472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</originalsourceid><addsrcrecordid>eNptkctv1DAQxiMEog-4cUZGXDiQ4ldi-1KpWgqsVIlLOVve7CRxlY1T26m0_z2zyrIqiMvY8vz8zeMrineMXjEq9Bc3pStOGcegXxTnTMmqVLySL_FeK1ZKqsVZcZHSA6WCC2ZeF2dcVFxWSpwXw03K0XVuCMlvgazXJEffdRATuScNDANxTfZPLvswktzHMHc9idDNw_IUWrL6KisyxZDBI7KPqDQCmfqQpt5ll2CR8Hn_pnjVuiHB2-N5Wfz6dnu_-lHe_fy-Xt3clY1UdS6Z2ypHgdVbMLRVXAotpQFNVd2C0XojteNGtQJA0s2mdtK4ujXbmgqhoa3FZXG96E7zZgfbBkaccbBT9DsX9zY4b__OjL63XXiyklKuTIUCn44CMTzOkLLd-XTYhhshzMkygU0ZKhVH9OM_6EOY44jjHSihlcCVI_V5oRpcT4rQnpph1B5stGijPdiIQSP-_vkAJ_iPbwiUC5AwNaJdz6r-X_DDsX4fxu4Rv5w0ZVUxbYwSvwH047Ru</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1323873319</pqid></control><display><type>article</type><title>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Wan, Chun-ping ; Gao, Li-xin ; Hou, Li-fei ; Yang, Xiao-qian ; He, Pei-lan ; Yang, Yi-fu ; Tang, Wei ; Yue, Jian-min ; Li, Jia ; Zuo, Jian-ping</creator><creatorcontrib>Wan, Chun-ping ; Gao, Li-xin ; Hou, Li-fei ; Yang, Xiao-qian ; He, Pei-lan ; Yang, Yi-fu ; Tang, Wei ; Yue, Jian-min ; Li, Jia ; Zuo, Jian-ping</creatorcontrib><description>Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases.</description><identifier>ISSN: 1671-4083</identifier><identifier>EISSN: 1745-7254</identifier><identifier>DOI: 10.1038/aps.2012.208</identifier><identifier>PMID: 23524573</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animals ; Astragalus membranaceus - chemistry ; Astragalus membranaceus - immunology ; Biomedical and Life Sciences ; Biomedicine ; CD3 Complex - genetics ; CD3 Complex - immunology ; CD3 Complex - metabolism ; CD4-Positive T-Lymphocytes - drug effects ; CD4-Positive T-Lymphocytes - immunology ; CD4-Positive T-Lymphocytes - metabolism ; Female ; Immunology ; Interferon-gamma - genetics ; Interferon-gamma - immunology ; Interferon-gamma - metabolism ; Interleukin-2 - immunology ; Interleukin-2 - metabolism ; Internal Medicine ; Leukocyte Common Antigens - immunology ; Leukocyte Common Antigens - metabolism ; Lymphocyte Activation - drug effects ; Medical Microbiology ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; mRNA水平 ; Original ; original-article ; Pharmacology/Toxicology ; Protein Tyrosine Phosphatases - immunology ; Protein Tyrosine Phosphatases - metabolism ; Random Allocation ; Saponins - immunology ; Saponins - pharmacology ; T-Lymphocytes - drug effects ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; Tyrosine - immunology ; Tyrosine - metabolism ; T细胞活化 ; Vaccine ; 免疫抑制剂 ; 免疫调节活性 ; 比色法测定 ; 脾细胞增殖 ; 蛋白酪氨酸磷酸酶 ; 黄芪皂苷</subject><ispartof>Acta pharmacologica Sinica, 2013-04, Vol.34 (4), p.522-530</ispartof><rights>CPS and SIMM 2013</rights><rights>Copyright Nature Publishing Group Apr 2013</rights><rights>Copyright © 2013 CPS and SIMM 2013 CPS and SIMM</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</citedby><cites>FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/95561A/95561A.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002795/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002795/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23524573$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wan, Chun-ping</creatorcontrib><creatorcontrib>Gao, Li-xin</creatorcontrib><creatorcontrib>Hou, Li-fei</creatorcontrib><creatorcontrib>Yang, Xiao-qian</creatorcontrib><creatorcontrib>He, Pei-lan</creatorcontrib><creatorcontrib>Yang, Yi-fu</creatorcontrib><creatorcontrib>Tang, Wei</creatorcontrib><creatorcontrib>Yue, Jian-min</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Zuo, Jian-ping</creatorcontrib><title>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</title><title>Acta pharmacologica Sinica</title><addtitle>Acta Pharmacol Sin</addtitle><addtitle>Acta Pharmacologica Sinica</addtitle><description>Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases.</description><subject>Animals</subject><subject>Astragalus membranaceus - chemistry</subject><subject>Astragalus membranaceus - immunology</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>CD3 Complex - genetics</subject><subject>CD3 Complex - immunology</subject><subject>CD3 Complex - metabolism</subject><subject>CD4-Positive T-Lymphocytes - drug effects</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD4-Positive T-Lymphocytes - metabolism</subject><subject>Female</subject><subject>Immunology</subject><subject>Interferon-gamma - genetics</subject><subject>Interferon-gamma - immunology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interleukin-2 - immunology</subject><subject>Interleukin-2 - metabolism</subject><subject>Internal Medicine</subject><subject>Leukocyte Common Antigens - immunology</subject><subject>Leukocyte Common Antigens - metabolism</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Medical Microbiology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>mRNA水平</subject><subject>Original</subject><subject>original-article</subject><subject>Pharmacology/Toxicology</subject><subject>Protein Tyrosine Phosphatases - immunology</subject><subject>Protein Tyrosine Phosphatases - metabolism</subject><subject>Random Allocation</subject><subject>Saponins - immunology</subject><subject>Saponins - pharmacology</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><subject>Tyrosine - immunology</subject><subject>Tyrosine - metabolism</subject><subject>T细胞活化</subject><subject>Vaccine</subject><subject>免疫抑制剂</subject><subject>免疫调节活性</subject><subject>比色法测定</subject><subject>脾细胞增殖</subject><subject>蛋白酪氨酸磷酸酶</subject><subject>黄芪皂苷</subject><issn>1671-4083</issn><issn>1745-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkctv1DAQxiMEog-4cUZGXDiQ4ldi-1KpWgqsVIlLOVve7CRxlY1T26m0_z2zyrIqiMvY8vz8zeMrineMXjEq9Bc3pStOGcegXxTnTMmqVLySL_FeK1ZKqsVZcZHSA6WCC2ZeF2dcVFxWSpwXw03K0XVuCMlvgazXJEffdRATuScNDANxTfZPLvswktzHMHc9idDNw_IUWrL6KisyxZDBI7KPqDQCmfqQpt5ll2CR8Hn_pnjVuiHB2-N5Wfz6dnu_-lHe_fy-Xt3clY1UdS6Z2ypHgdVbMLRVXAotpQFNVd2C0XojteNGtQJA0s2mdtK4ujXbmgqhoa3FZXG96E7zZgfbBkaccbBT9DsX9zY4b__OjL63XXiyklKuTIUCn44CMTzOkLLd-XTYhhshzMkygU0ZKhVH9OM_6EOY44jjHSihlcCVI_V5oRpcT4rQnpph1B5stGijPdiIQSP-_vkAJ_iPbwiUC5AwNaJdz6r-X_DDsX4fxu4Rv5w0ZVUxbYwSvwH047Ru</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Wan, Chun-ping</creator><creator>Gao, Li-xin</creator><creator>Hou, Li-fei</creator><creator>Yang, Xiao-qian</creator><creator>He, Pei-lan</creator><creator>Yang, Yi-fu</creator><creator>Tang, Wei</creator><creator>Yue, Jian-min</creator><creator>Li, Jia</creator><creator>Zuo, Jian-ping</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130401</creationdate><title>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</title><author>Wan, Chun-ping ; Gao, Li-xin ; Hou, Li-fei ; Yang, Xiao-qian ; He, Pei-lan ; Yang, Yi-fu ; Tang, Wei ; Yue, Jian-min ; Li, Jia ; Zuo, Jian-ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Astragalus membranaceus - chemistry</topic><topic>Astragalus membranaceus - immunology</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>CD3 Complex - genetics</topic><topic>CD3 Complex - immunology</topic><topic>CD3 Complex - metabolism</topic><topic>CD4-Positive T-Lymphocytes - drug effects</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD4-Positive T-Lymphocytes - metabolism</topic><topic>Female</topic><topic>Immunology</topic><topic>Interferon-gamma - genetics</topic><topic>Interferon-gamma - immunology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interleukin-2 - immunology</topic><topic>Interleukin-2 - metabolism</topic><topic>Internal Medicine</topic><topic>Leukocyte Common Antigens - immunology</topic><topic>Leukocyte Common Antigens - metabolism</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Medical Microbiology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>mRNA水平</topic><topic>Original</topic><topic>original-article</topic><topic>Pharmacology/Toxicology</topic><topic>Protein Tyrosine Phosphatases - immunology</topic><topic>Protein Tyrosine Phosphatases - metabolism</topic><topic>Random Allocation</topic><topic>Saponins - immunology</topic><topic>Saponins - pharmacology</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><topic>Tyrosine - immunology</topic><topic>Tyrosine - metabolism</topic><topic>T细胞活化</topic><topic>Vaccine</topic><topic>免疫抑制剂</topic><topic>免疫调节活性</topic><topic>比色法测定</topic><topic>脾细胞增殖</topic><topic>蛋白酪氨酸磷酸酶</topic><topic>黄芪皂苷</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wan, Chun-ping</creatorcontrib><creatorcontrib>Gao, Li-xin</creatorcontrib><creatorcontrib>Hou, Li-fei</creatorcontrib><creatorcontrib>Yang, Xiao-qian</creatorcontrib><creatorcontrib>He, Pei-lan</creatorcontrib><creatorcontrib>Yang, Yi-fu</creatorcontrib><creatorcontrib>Tang, Wei</creatorcontrib><creatorcontrib>Yue, Jian-min</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Zuo, Jian-ping</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta pharmacologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wan, Chun-ping</au><au>Gao, Li-xin</au><au>Hou, Li-fei</au><au>Yang, Xiao-qian</au><au>He, Pei-lan</au><au>Yang, Yi-fu</au><au>Tang, Wei</au><au>Yue, Jian-min</au><au>Li, Jia</au><au>Zuo, Jian-ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</atitle><jtitle>Acta pharmacologica Sinica</jtitle><stitle>Acta Pharmacol Sin</stitle><addtitle>Acta Pharmacologica Sinica</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>34</volume><issue>4</issue><spage>522</spage><epage>530</epage><pages>522-530</pages><issn>1671-4083</issn><eissn>1745-7254</eissn><abstract>Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>23524573</pmid><doi>10.1038/aps.2012.208</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1671-4083
ispartof Acta pharmacologica Sinica, 2013-04, Vol.34 (4), p.522-530
issn 1671-4083
1745-7254
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4002795
source MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Animals
Astragalus membranaceus - chemistry
Astragalus membranaceus - immunology
Biomedical and Life Sciences
Biomedicine
CD3 Complex - genetics
CD3 Complex - immunology
CD3 Complex - metabolism
CD4-Positive T-Lymphocytes - drug effects
CD4-Positive T-Lymphocytes - immunology
CD4-Positive T-Lymphocytes - metabolism
Female
Immunology
Interferon-gamma - genetics
Interferon-gamma - immunology
Interferon-gamma - metabolism
Interleukin-2 - immunology
Interleukin-2 - metabolism
Internal Medicine
Leukocyte Common Antigens - immunology
Leukocyte Common Antigens - metabolism
Lymphocyte Activation - drug effects
Medical Microbiology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
mRNA水平
Original
original-article
Pharmacology/Toxicology
Protein Tyrosine Phosphatases - immunology
Protein Tyrosine Phosphatases - metabolism
Random Allocation
Saponins - immunology
Saponins - pharmacology
T-Lymphocytes - drug effects
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Tyrosine - immunology
Tyrosine - metabolism
T细胞活化
Vaccine
免疫抑制剂
免疫调节活性
比色法测定
脾细胞增殖
蛋白酪氨酸磷酸酶
黄芪皂苷
title Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A58%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Astragaloside%20II%20triggers%20T%20cell%20activation%20through%20regulation%20of%20CD45%20protein%20tyrosine%20phosphatase%20activity&rft.jtitle=Acta%20pharmacologica%20Sinica&rft.au=Wan,%20Chun-ping&rft.date=2013-04-01&rft.volume=34&rft.issue=4&rft.spage=522&rft.epage=530&rft.pages=522-530&rft.issn=1671-4083&rft.eissn=1745-7254&rft_id=info:doi/10.1038/aps.2012.208&rft_dat=%3Cproquest_pubme%3E1324390472%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1323873319&rft_id=info:pmid/23524573&rft_cqvip_id=45518997&rfr_iscdi=true